secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2024-04-22T23:59:59+00:00
Accession:  0001628280-24-017112
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics raises $77.5M in public offering; over-allotment exercised
--------------------------------------------------------------------------------

- Underwriters exercised over-allotment for 559,801 shares at $4.50 on April 22, 2024.
- Total gross proceeds approximate $77.5M from 17.2M shares issued.
- Offering co-managed by Leerink Partners, Piper Sandler; Oppenheimer as lead manager.
- Over-allotment exercised 30 days after initial closing of March 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024017112/0001628280-24-017112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024017112/aqst-20240422.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-017112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer